Early detection and continuous care have become essential in managing schizophrenia and psychotic disorders, which often emerge during adolescence or early adulthood. Recent advances highlight the importance of coordinated specialty care, combining antipsychotic medication, social support, and cognitive behavioral therapy. Neuroimaging and genetic studies continue to uncover biomarkers linked to psychotic symptoms, improving diagnostic accuracy. Innovations such as digital monitoring tools and long-acting injectable medications enhance treatment adherence and functional outcomes. Psychosocial rehabilitation remains a cornerstone, helping individuals build life skills, re-enter the workforce, and maintain meaningful relationships. Integrating neuroscience, clinical care, and social services offers a more holistic approach to sustained recovery.